National Comprehensive Cancer Network

|
|
|
|
For Patients

NCCN Research & Business Resources


The Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Chicago, Illinois
Administrative Office: 312.908.5250
Patient Referrals: 866.LURIECC (587.4322)

www.cancer.northwestern.edu

Learn more about clinical trials at this NCCN Member Institution.

Profile

The Robert H. Lurie Comprehensive Cancer Center is dedicated to the process of discovery, advancing medical knowledge, and providing compassionate, state-of-the-art cancer care. Outstanding basic, translational, and clinical research complements a full range of prevention, early detection, treatment, rehabilitation, and palliative care programs for all types of cancer. Primary and tertiary programs on the main medical center campus treat nearly 10,000 new cancer cases annually and the Center additionally maintains affiliations with four teaching hospitals located throughout the metropolitan Chicago area. Across this system, more than 2,000 patients are annually accrued to approximately 220 clinical trials conducted by the Center.

· The Cancer Center has major research strengths in breast, genitourinary, gastrointestinal, aerodigestive, neurologic, and gynecologic cancers; hematologic malignancies; and pediatric oncology. Basic and translational research programs in hormone action/signal transduction, angiogenesis, biologic therapies, and nanotechnology are nationally and internationally recognized. Overall, the Center's 250 clinicians and scientists generate in excess of $130 million annually in extramural grant funding.

· A full range of medical, surgical, and radiation oncology treatment facilities is complemented by exceptional screening facilities and programs for breast, prostate, colon, and ovarian cancers; a comprehensive, multidisciplinary breast center; the region's leading genetic testing and counseling service; a model academic Hospice/Palliative Medicine Program that has achieved national prominence; and a novel, comprehensive program in liver-directed therapies that includes surgeons, medical oncologists, and interventional radiologists.

In 2003, the Cancer Center dedicated a new 32,000 sq. ft. ambulatory cancer care facility which provides comprehensive, multidisciplinary care including hematology/oncology, surgical subspecialties, radiation oncology, and psycho-social care.

In October 2007, a new and expanded Lynn Sage Comprehensive Breast Center, as well as all new inpatient Hematology/Oncology units, came online with 72 beds. These state-of-the-art facilities provide expanded capacity in all cancer diagnostic areas.